Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of HMB-001 for Patients with Glanzmann Thrombasthenia
ItalyStudy on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation
ItalyStudy on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer
ItalyStudy on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery
ItalyStudy on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma
ItalyStudy on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials
ItalyStudy on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause
ItalyStudy of Cabozantinib and Durvalumab for Patients with Advanced Bladder Cancer After Chemotherapy
ItalyStudy on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors
ItalyStudy on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression
ItalyStudy on the Effectiveness and Safety of Tinengotinib for Patients with Cholangiocarcinoma Resistant to Chemotherapy and FGFR Inhibitors
ItalyStudy of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
